Antoni Vilaseca Cabo, MD, discusses phase 1 data presented on TAR-210 for the treatment of patients with FGFR-altered high- ...

During a Case-Based Roundtable® event, Jubilee Brown, MD, discussed the efficacy and safety data from the KEYNOTE-775/Study ...

During a Case-Based Roundtable® event, Evan J. Lipson, MD, discussed with participants whether factors such as patient ...

Halle Moore, MD, discusses some of the main concerns that patients with breast cancer have about fertility after treatment.

During a Case-Based Roundtable® event, Michael B. Atkins, MD, discussed the choice of therapy for a 78-year-old patient with ...

The FDA accelerated approval of tarlatamab makes it the first bispecific T-cell engager therapy for a major solid tumor.

In this episode of Targeted Talks, Nini Wu, MD, MBA, shares her insights on the ever-changing world of technology in ...

During a Case-Based Roundtable® event, Julia Rotow, MD, led a discussion on the non-clinical barriers that impact the use of ...

For Melanoma and Skin Cancer Awareness Month, Nayoung Lee, MD, discussed evolving paradigms in skin cancer diagnosis and ...

HPV self-collection solution is an accessible screening option for women, offering an alternative option compared with the ...

In an interview with Targeted Oncology for Brain Cancer Awareness Month, Theodore Schwartz, MD, discussed the challenges of ...

SNB-101, a nanoparticle drug for small cell lung cancer, received a fast track designation from the FDA for expedited ...